advertisement
Sakata R 23
Showing records 1 to 23 | Display all abstracts from Sakata R112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Sakata R
Eye 2024; 38: 737-744
113270 Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Fujita A
Eye 2024; 38: 930-936
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Sakata R
Japanese Journal of Ophthalmology 2023; 67: 668-677
112247 Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Aoyama Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 191-201
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Araie M
Eye 2024; 38: 737-744
113270 Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Konishi T
Eye 2024; 38: 930-936
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Mizoue S
Japanese Journal of Ophthalmology 2023; 67: 668-677
112247 Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Sakata R
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 191-201
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Yoshikawa K
Japanese Journal of Ophthalmology 2023; 67: 668-677
113270 Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Sakata R
Eye 2024; 38: 930-936
112247 Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Fujishiro T
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 191-201
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Yoshitomi T
Eye 2024; 38: 737-744
112247 Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Honjo M
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 191-201
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Adachi M
Japanese Journal of Ophthalmology 2023; 67: 668-677
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Eye 2024; 38: 737-744
113270 Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Hashimoto Y
Eye 2024; 38: 930-936
112247 Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Shirato S
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 191-201
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Ohkubo S
Japanese Journal of Ophthalmology 2023; 67: 668-677
113270 Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Yasunaga H
Eye 2024; 38: 930-936
112247 Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Aihara M
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 191-201
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Hamada N
Japanese Journal of Ophthalmology 2023; 67: 668-677
113270 Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Aihara M
Eye 2024; 38: 930-936
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Naito T; Muramatsu T; Hara T; Asato R; Aihara M
Japanese Journal of Ophthalmology 2023; 67: 668-677
